Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia A Ignatenko

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Biochemical Journal|July 16, 2003
Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithineNing Qu, Natalia A Ignatenko, Phillip Yamauchi, et al.
Cancer Genomics & Proteomics|June 3, 2009
Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047Natalia A Ignatenko, Hagit F Yerushalmi, Ritu Pandey, et al.
International Journal of Cancer|November 11, 2006
Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survivalJason A Zell, Natalia A Ignatenko, Hagit F Yerushalmi, et al.
Viruses|October 29, 2025
Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 InfectionNatalia A Ignatenko, Hien T Trinh, April M Wagner, et al.
Technology in Cancer Research & Treatment|November 24, 2006
Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161Natalia A Ignatenko, Hagit F Yerushalmi, George S Watts, et al.
Cancers|November 27, 2024
Kallikrein-Related Peptidase 6 Contributes to Murine Intestinal Tumorigenesis Driven by a Mutant <i>Adenomatous polyposis coli</i> GeneTeodora G Georgieva, Dalila Darmoul, Hwudaurw Chen, et al.
Frontiers in Oncology|February 2, 2023
Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteinsKendra D Marr, Natalia A Ignatenko, Noel A Warfel, et al.
Biomolecules|July 27, 2022
Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal MetastasisHayet Bouzid, Feryel Soualmia, Katerina Oikonomopoulou, et al.
Oncotarget|November 7, 2019
Kallikrein 6 protease advances colon tumorigenesis <i>via</i> induction of the high mobility group A2 proteinHwudaurw Chen, Earlphia Sells, Ritu Pandey, et al.
Nutrition and Cancer|May 4, 2007
Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposisNatalia A Ignatenko, David G Besselsen, Upal K Basu Roy, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|July 16, 2003
Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithineNing Qu, Natalia A Ignatenko, Phillip Yamauchi, et al.
Cancer Genomics & Proteomics|June 3, 2009
Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047Natalia A Ignatenko, Hagit F Yerushalmi, Ritu Pandey, et al.
International Journal of Cancer|November 11, 2006
Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survivalJason A Zell, Natalia A Ignatenko, Hagit F Yerushalmi, et al.
Viruses|October 29, 2025
Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 InfectionNatalia A Ignatenko, Hien T Trinh, April M Wagner, et al.
Technology in Cancer Research & Treatment|November 24, 2006
Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161Natalia A Ignatenko, Hagit F Yerushalmi, George S Watts, et al.
Cancers|November 27, 2024
Kallikrein-Related Peptidase 6 Contributes to Murine Intestinal Tumorigenesis Driven by a Mutant <i>Adenomatous polyposis coli</i> GeneTeodora G Georgieva, Dalila Darmoul, Hwudaurw Chen, et al.
Frontiers in Oncology|February 2, 2023
Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteinsKendra D Marr, Natalia A Ignatenko, Noel A Warfel, et al.
Biomolecules|July 27, 2022
Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal MetastasisHayet Bouzid, Feryel Soualmia, Katerina Oikonomopoulou, et al.
Oncotarget|November 7, 2019
Kallikrein 6 protease advances colon tumorigenesis <i>via</i> induction of the high mobility group A2 proteinHwudaurw Chen, Earlphia Sells, Ritu Pandey, et al.
Nutrition and Cancer|May 4, 2007
Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposisNatalia A Ignatenko, David G Besselsen, Upal K Basu Roy, et al.
Pageof 4